Ventyx Biosciences, Inc.
VTYX
$1.20
-$0.06-4.76%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 37.22% | 34.76% | 40.00% | 0.92% | -32.77% |
| Total Depreciation and Amortization | -21.84% | 16.60% | 127.34% | 204.48% | 168.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -21.83% | -51.64% | -43.76% | 0.45% | 27.75% |
| Change in Net Operating Assets | 129.12% | -125.41% | 363.22% | -512.46% | 39.46% |
| Cash from Operations | 54.99% | -2.30% | 50.21% | -54.02% | -9.29% |
| Capital Expenditure | 97.16% | 100.00% | 69.23% | -191.67% | -88.39% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -123.72% | -24.89% | -315.51% | 322.67% | 132.93% |
| Cash from Investing | -123.84% | -24.80% | -316.89% | 321.04% | 132.75% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -48.85% | -99.30% | -- | 97.62% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -104.27% | 1,553.05% | -136.64% | 97.72% | 105.65% |
| Foreign Exchange rate Adjustments | -170.93% | 1,100.00% | -123.68% | -125.00% | -1,175.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -585.85% | 255.15% | -744.82% | 7,953.83% | 97.46% |